Canandaigua National Corp Regeneron Pharmaceuticals, Inc. Transaction History

Canandaigua National Corp

  • $589 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 05, 2021
SELL
$446.73 - $548.2 $1.24 Million - $1.52 Million
-2,779 Closed
0 $0
Q4 2020

Feb 11, 2021
SELL
$478.3 - $607.98 $5,739 - $7,295
-12 Reduced 0.43%
2,779 $1.34 Million
Q3 2020

Oct 19, 2020
SELL
$544.75 - $658.21 $58,288 - $70,428
-107 Reduced 3.69%
2,791 $1.56 Million
Q2 2020

Jul 07, 2020
BUY
$493.32 - $643.92 $1.43 Million - $1.87 Million
2,898 New
2,898 $1.81 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Canandaigua National Corp Portfolio

Follow Canandaigua National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email